Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-115432

President and CEO sold 58,726 shares at an average $25.77 ($1,513,271)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd President and CEO 2024-10-15 Sale 10b5-1 −10,035 $24.31 $243,970 1,467,338 D: show line 1 in the form
Harris Todd President and CEO 2024-10-16 Sale 10b5-1 −4,900 $25.22 $123,556 1,462,438 D: show line 2 in the form
Harris Todd President and CEO 2024-10-16 Sale 10b5-1 −24,475 $26.23 $642,062 1,437,963 D: show line 3 in the form
Harris Todd President and CEO 2024-10-16 Sale 10b5-1 −3,922 $26.98 $105,811 1,434,041 D: show line 4 in the form
Harris Todd President and CEO 2024-10-17 Sale 10b5-1 −15,194 $25.84 $392,598 1,418,847 D: show line 5 in the form
Harris Todd President and CEO 2024-10-17 Sale 10b5-1 −200 $26.37 $5,274 1,418,647 D: show line 6 in the form
Open-market sales · 58,726 sh · avg $25.77 · $1,513,271
Loading xslF345X05/ownership.xml…